Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goodman Corey S
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   12,296,786    

Indirect Shares

   8,829,949      
Direct Value   $340,985,692    

Indirect Value

   $49,560,123      
Total Shares   21,126,735      
Total Value   $390,545,815      


Pfizer Inc $2,303,318 Metacrine, Inc. $0 Ventyx Biosciences, Inc. $16,348,830 Rayzebio, Inc. $322,333,543 Pfizer Inc $2,303,318 Metacrine, Inc. $0 Ventyx Biosciences, Inc. $16,348,830 Rayzebio, Inc. $322,333,543
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -27.8%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Renovis Inc RNVS Director 2008-05-02 0 2008-05-02 0    Premium*  
            Pfizer Inc PFE Senior Vice President 2009-02-26 82,232 2009-02-26 1,095    Premium*  
            Precision Biosciences Inc DTIL 10% Owner 2019-04-01 0 2019-04-01 4,265,141    Premium*  
            Akero Therapeutics, Inc. AKRO 2019-06-24 0 2020-07-06 3,033,552    Premium*  
            Alx Oncology Holdings Inc ALXO Executive Chairman, Di... 0 2020-07-21 515,894    Premium*  
            Metacrine, Inc. MTCR 2020-09-18 3,059,123 2020-09-18 0    Premium*  
            Ventyx Biosciences, Inc. VTYX See Remarks, 10% Owner 2021-10-25 3,997,269 2021-10-25 1,014,267    Premium*  
            Rayzebio, Inc. RYZB 2023-09-19 5,158,162 2023-09-19 0    Premium*  
* Premium Members only  

Records found :    82         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2019-06-24 4 B $16.00 $4,000,000 I/I 250,000 250,000 1.5 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2019-06-24 4 A $0.00 $0 I/I 3,704,858 3,954,858 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2019-12-31 4 S $23.96 $343,259 I/I (14,324) 3,940,534 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-01-02 4 S $19.94 $458,507 I/I (23,000) 3,917,534 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-01-03 4 S $19.30 $241,214 I/I (12,498) 3,905,036 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-01-06 4 S $19.64 $829,381 I/I (42,221) 3,862,815 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-01-07 4 S $20.17 $625,149 I/I (31,000) 3,831,815 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-01-08 4 S $19.86 $311,355 I/I (15,677) 3,816,138 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-01-13 4 S $20.23 $9,993,620 I/I (494,000) 3,322,138 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-04 4 S $25.65 $1,378,179 I/I (53,731) 3,268,407 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-05 4 S $25.99 $743,548 I/I (28,608) 3,239,799 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-06 4 S $27.03 $164,955 I/I (6,102) 3,233,697 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-10 4 S $27.08 $212,168 I/I (7,836) 3,225,861 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-11 4 S $27.05 $59,068 I/I (2,184) 3,233,677 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-12 4 S $27.14 $163 I/I (6) 3,233,671 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-25 4 S $23.67 $37,876 I/I (1,600) 3,232,071 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-26 4 S $22.44 $56,615 I/I (2,523) 3,229,548 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-27 4 S $22.54 $40,144 I/I (1,781) 3,227,767 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-02-28 4 S $21.30 $108,652 I/I (5,100) 3,212,667 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-03-02 4 S $23.06 $237,459 I/I (10,297) 3,202,370 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-03-03 4 S $23.00 $147,199 I/I (6,401) 3,195,969 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-03-04 4 S $23.81 $848,766 I/I (35,650) 3,160,319 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-03-05 4 S $23.53 $200,011 I/I (8,500) 3,151,819 0 -
AKRO Akero Therapeutics, Inc. 10% Owner   –       –       •   2020-03-06 4 S $23.79 $42,831 I/I (1,800) 3,150,019 0 -
AKRO Akero Therapeutics, Inc.   •       •       •   2020-07-01 4 S $34.45 $3,723,010 I/I (108,064) 3,041,955 0 -
  82  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us